Doxorubicin-induced cardiotoxicity

Direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27

Samir Turakhia, C. D. Venkatakrishnan, Kathy Dunsmore, Hector Wong, Periannan Kuppusamy, Jay L. Zweier, Govindasamy Ilangovan

Research output: Contribution to journalArticle

Abstract

The use of doxorubicin (Dox) and its derivatives as chemotherapeutic drugs to treat patients with cancer causes dilated cardiomyopathy and congestive heart failure due to Dox-induced cardiotoxicity. In this work, using heat shock factor-1 wild-type (HSF-1+/+) and HSF-1 knockout (HSF-1 -/-) mouse fibroblasts and embryonic rat heart-derived cardiac H9c2 cells, we show that the magnitude of protection from Dox-induced toxicity directly correlates with the level of the heat shock protein 27 (HSP27). Western blot analysis of normal and heat-shocked cells showed the maximum expression of HSP27 in heat-shocked cardiac H9c2 cells and no HSP27 in HSF-1-/- cells (normal or heat-shocked). Correspondingly, the cell viability, measured [with (3,4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay] after treatment with various concentrations of Dox, was the highest in heat-shocked H9c2 cells and the lowest in HSF-1-/- cells. Depleting HSP27 in cardiac H9c2 cells by small interfering (si)RNA also reduced the viability against Dox, confirming that HSP27 does protect cardiac cells against the Dox-induced toxicity. The cells that have lower HSP27 levels such as HSF-1-/-, were found to be more susceptible for aconitase inactivation. Based on these results we propose a novel mechanism that HSP27 plays an important role in protecting aconitase from Dox-generated O 2•-, by increasing SOD activity. Such a protection of aconitase by HSP27 eliminates the catalytic recycling of aconitase released Fe(II) and its deleterious effects in cardiac cells.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume293
Issue number5
DOIs
StatePublished - Nov 2007
Externally publishedYes

Fingerprint

HSP27 Heat-Shock Proteins
Aconitate Hydratase
Doxorubicin
Cell Survival
Fibroblasts
Hot Temperature
Cardiotoxicity
Dilated Cardiomyopathy
Knockout Mice
Small Interfering RNA
Shock
Heart Failure
Western Blotting

Keywords

  • Superoxide dismutase

ASJC Scopus subject areas

  • Physiology

Cite this

Doxorubicin-induced cardiotoxicity : Direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27. / Turakhia, Samir; Venkatakrishnan, C. D.; Dunsmore, Kathy; Wong, Hector; Kuppusamy, Periannan; Zweier, Jay L.; Ilangovan, Govindasamy.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 293, No. 5, 11.2007.

Research output: Contribution to journalArticle

Turakhia, Samir ; Venkatakrishnan, C. D. ; Dunsmore, Kathy ; Wong, Hector ; Kuppusamy, Periannan ; Zweier, Jay L. ; Ilangovan, Govindasamy. / Doxorubicin-induced cardiotoxicity : Direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27. In: American Journal of Physiology - Heart and Circulatory Physiology. 2007 ; Vol. 293, No. 5.
@article{3f120234523e473fad4eb64d6b7ddfe7,
title = "Doxorubicin-induced cardiotoxicity: Direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27",
abstract = "The use of doxorubicin (Dox) and its derivatives as chemotherapeutic drugs to treat patients with cancer causes dilated cardiomyopathy and congestive heart failure due to Dox-induced cardiotoxicity. In this work, using heat shock factor-1 wild-type (HSF-1+/+) and HSF-1 knockout (HSF-1 -/-) mouse fibroblasts and embryonic rat heart-derived cardiac H9c2 cells, we show that the magnitude of protection from Dox-induced toxicity directly correlates with the level of the heat shock protein 27 (HSP27). Western blot analysis of normal and heat-shocked cells showed the maximum expression of HSP27 in heat-shocked cardiac H9c2 cells and no HSP27 in HSF-1-/- cells (normal or heat-shocked). Correspondingly, the cell viability, measured [with (3,4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay] after treatment with various concentrations of Dox, was the highest in heat-shocked H9c2 cells and the lowest in HSF-1-/- cells. Depleting HSP27 in cardiac H9c2 cells by small interfering (si)RNA also reduced the viability against Dox, confirming that HSP27 does protect cardiac cells against the Dox-induced toxicity. The cells that have lower HSP27 levels such as HSF-1-/-, were found to be more susceptible for aconitase inactivation. Based on these results we propose a novel mechanism that HSP27 plays an important role in protecting aconitase from Dox-generated O 2•-, by increasing SOD activity. Such a protection of aconitase by HSP27 eliminates the catalytic recycling of aconitase released Fe(II) and its deleterious effects in cardiac cells.",
keywords = "Superoxide dismutase",
author = "Samir Turakhia and Venkatakrishnan, {C. D.} and Kathy Dunsmore and Hector Wong and Periannan Kuppusamy and Zweier, {Jay L.} and Govindasamy Ilangovan",
year = "2007",
month = "11",
doi = "10.1152/ajpheart.00328.2007",
language = "English (US)",
volume = "293",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - Doxorubicin-induced cardiotoxicity

T2 - Direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27

AU - Turakhia, Samir

AU - Venkatakrishnan, C. D.

AU - Dunsmore, Kathy

AU - Wong, Hector

AU - Kuppusamy, Periannan

AU - Zweier, Jay L.

AU - Ilangovan, Govindasamy

PY - 2007/11

Y1 - 2007/11

N2 - The use of doxorubicin (Dox) and its derivatives as chemotherapeutic drugs to treat patients with cancer causes dilated cardiomyopathy and congestive heart failure due to Dox-induced cardiotoxicity. In this work, using heat shock factor-1 wild-type (HSF-1+/+) and HSF-1 knockout (HSF-1 -/-) mouse fibroblasts and embryonic rat heart-derived cardiac H9c2 cells, we show that the magnitude of protection from Dox-induced toxicity directly correlates with the level of the heat shock protein 27 (HSP27). Western blot analysis of normal and heat-shocked cells showed the maximum expression of HSP27 in heat-shocked cardiac H9c2 cells and no HSP27 in HSF-1-/- cells (normal or heat-shocked). Correspondingly, the cell viability, measured [with (3,4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay] after treatment with various concentrations of Dox, was the highest in heat-shocked H9c2 cells and the lowest in HSF-1-/- cells. Depleting HSP27 in cardiac H9c2 cells by small interfering (si)RNA also reduced the viability against Dox, confirming that HSP27 does protect cardiac cells against the Dox-induced toxicity. The cells that have lower HSP27 levels such as HSF-1-/-, were found to be more susceptible for aconitase inactivation. Based on these results we propose a novel mechanism that HSP27 plays an important role in protecting aconitase from Dox-generated O 2•-, by increasing SOD activity. Such a protection of aconitase by HSP27 eliminates the catalytic recycling of aconitase released Fe(II) and its deleterious effects in cardiac cells.

AB - The use of doxorubicin (Dox) and its derivatives as chemotherapeutic drugs to treat patients with cancer causes dilated cardiomyopathy and congestive heart failure due to Dox-induced cardiotoxicity. In this work, using heat shock factor-1 wild-type (HSF-1+/+) and HSF-1 knockout (HSF-1 -/-) mouse fibroblasts and embryonic rat heart-derived cardiac H9c2 cells, we show that the magnitude of protection from Dox-induced toxicity directly correlates with the level of the heat shock protein 27 (HSP27). Western blot analysis of normal and heat-shocked cells showed the maximum expression of HSP27 in heat-shocked cardiac H9c2 cells and no HSP27 in HSF-1-/- cells (normal or heat-shocked). Correspondingly, the cell viability, measured [with (3,4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay] after treatment with various concentrations of Dox, was the highest in heat-shocked H9c2 cells and the lowest in HSF-1-/- cells. Depleting HSP27 in cardiac H9c2 cells by small interfering (si)RNA also reduced the viability against Dox, confirming that HSP27 does protect cardiac cells against the Dox-induced toxicity. The cells that have lower HSP27 levels such as HSF-1-/-, were found to be more susceptible for aconitase inactivation. Based on these results we propose a novel mechanism that HSP27 plays an important role in protecting aconitase from Dox-generated O 2•-, by increasing SOD activity. Such a protection of aconitase by HSP27 eliminates the catalytic recycling of aconitase released Fe(II) and its deleterious effects in cardiac cells.

KW - Superoxide dismutase

UR - http://www.scopus.com/inward/record.url?scp=36148985677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36148985677&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00328.2007

DO - 10.1152/ajpheart.00328.2007

M3 - Article

VL - 293

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 5

ER -